Outcomes4Me
Sucher für klinische Onkologie-Studien
Brustkrebs
Ort

Recruiting • Phasen NA • Stufe 0, I, II, III • Surgical • Post-Menopausal • Brain Metastases absent • Interventionell

Folgendes wird aus ClinicalTrials.gov importiert:

A Culturally Sensitive Social Support Intervention

This study is a randomized controlled trial (RCT) to assess the impact of a culturally based social support program (i.e. Joy Luck Academy, JLA) among Chinese American breast cancer survivors.

This study is a randomized controlled trial (RCT) to test the health benefits of an education and peer mentor support intervention. Chinese American breast cancer survivors who have completed primary treatment will be randomly assigned to either the intervention group or a control group to receive enhanced usual care while waiting for the JLA. Health outcomes are assessed at baseline, immediately post intervention, and 1 and 4 months follow-ups.

Breast Cancer

Studiendesign
Studientyp:

Interventional

Geschätzte Einschreibung:

168 Teilnehmer

Aktueller Studienbeginn:

20. Januar 2015

Zulassungskriterien
Alter für die Studie berechtigt:

18 - 999

Geschlechter für die Studie berechtigt:

female


Arms and Intervention
  • Social support intervention

Einschlusskriterien
  • self-identified to be comfortable speaking chinese (mandarin or cantonese)

  • having a first breast cancer diagnosis of stages 0-iii

  • having completed primary treatment (surgery, chemotherapy, or radiotherapy) within the last 36 months

Ausschlusskriterien
  • unable to read or speak chinese (mandarin or cantonese)

  • breast cancer diagnosis of stage iv

  • live outside of the la area

Trial Information at Site
Last Updated:
Studieninformationen
ClinicalTrial.gov ID:

Recruiting

Estimated Enrollment:

168

Last Updated:

02/24/2024


Trial Contact

Qian Lu, PhD; MD

qlu@mdanderson.org

713-745-8324


Lenna Dawkins-Moultin, PhD

ldawkins@mdanderson.org

713-792-0005


Hauptermittler

Qian Lu, PhD; MD


Studiensponsor

M.D. Anderson Cancer Center

Study Location (1)

Herald Cancer Association

Los Angeles, California, United States

Outcomes4Me

© 2024 Outcomes4Me Inc. All rights reserved.